The new face of anaphylatoxins in immune regulation

Immunobiology

Volumn 217, Issue 2, 2012, Pages 225-234

  Zhou, Wuding ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Anaphylatoxins; C3a; C5a; Dendritic cells; Immune regulation; T cell responses

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A;

ADAPTIVE IMMUNITY; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TARGET CELL; TH1 CELL; TH17 CELL; TH2 CELL;

ADAPTIVE IMMUNITY; ANAPHYLATOXINS; ANIMALS; COMPLEMENT ACTIVATION; DENDRITIC CELLS; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84855275942     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.07.016     Document Type: Review

References (74)

1. Ali H., Panettieri R.A. Anaphylatoxin C3a receptors in asthma. Respir. Res. 2005, 6:19.
2. Ames R.S., Li Y., Sarau H.M., Nuthulaganti P., Foley J.J., Ellis C., Zeng Z., Su K., Jurewicz A.J., Hertzberg R.P., Bergsma D.J., Kumar C. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 1996, 271:20231-20234.
3. Bamberg C.E., Mackay C.R., Lee H., Zahra D., Jackson J., Lim Y.S., Whitfeld P.L., Craig S., Corsini E., Lu B., Gerard C., Gerard N.P. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J. Biol. Chem. 2010, 285:7633-7644.
4. Banda N.K., Thurman J.M., Kraus D., Wood A., Carroll M.C., Arend W.P., Holers V.M. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J. Immunol. 2006, 177:1904-1912.
5. Baruah P., Dumitriu I.E., Malik T.H., Cook H.T., Dyson J., Scott D., Simpson E., Botto M. C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells. Blood 2009, 113:3485-3493.
6. Boulay F., Mery L., Tardif M., Brouchon L., Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 1991, 30:2993-2999.
7. Cain S.A., Monk P.N. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 2002, 277:7165-7169.
8. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 1998, 16:545-568.
9. Cavaillon J.M., Fitting C., Haeffner-Cavaillon N. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur. J. Immunol. 1990, 20:253-257.
10. Colten H.R., Ooi Y.M., Edelson P.J. Synthesis and secretion of complement proteins by macrophages. Ann. N. Y. Acad. Sci. 1979, 332:482-490.
11. Drouin S.M., Corry D.B., Hollman T.J., Kildsgaard J., Wetsel R.A. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 2002, 169:5926-5933.
12. Drouin S.M., Sinha M., Sfyroera G., Lambris J.D., Wetsel R.A. A protective role for the fifth complement component (C5) in allergic airway disease. Am. J. Respir. Crit. Care Med. 2006, 173:852-857.
13. Fang C., Miwa T., Shen H., Song W.C. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice. J. Immunol. 2007, 179:3178-3186.
14. Fang C., Zhang X., Miwa T., Song W.C. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 2009, 114:1005-1015.
15. Farrar C.A., Zhou W., Lin T., Sacks S.H. Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J. 2006, 20:217-226.
16. Fearon D.T., Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 2000, 18:393-422.
17. Fukuoka Y., Xia H.Z., Sanchez-Munoz L.B., Dellinger A.L., Escribano L., Schwartz L.B. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5. J. Immunol. 2008, 180:6307-6316.
18. Gasque P., Dean Y.D., McGreal E.P., VanBeek J., Morgan B.P. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 2000, 49:171-186.
19. Gerard C., Bao L., Orozco O., Pearson M., Kunz D., Gerard N.P. Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor. J. Immunol. 1992, 149:2600-2606.
20. Gerard N.P., Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature 1991, 349:614-617.
21. Gueler F., Rong S., Gwinner W., Mengel M., Brocker V., Schon S., Greten T.F., Hawlisch H., Polakowski T., Schnatbaum K., Menne J., Haller H., Shushakova N. Complement 5a receptor inhibition improves renal allograft survival. J. Am. Soc. Nephrol. 2008, 19:2302-2312.
22. Gutzmer R., Kother B., Zwirner J., Dijkstra D., Purwar R., Wittmann M., Werfel T. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a. J. Invest. Dermatol. 2006, 126:2422-2429.
23. Gutzmer R., Lisewski M., Zwirner J., Mommert S., Diesel C., Wittmann M., Kapp A., Werfel T. Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons. Immunology 2004, 111:435-443.
24. Hashimoto M., Hirota K., Yoshitomi H., Maeda S., Teradaira S., Akizuki S., Prieto-Martin P., Nomura T., Sakaguchi N., Köhl J., Heyman B., Takahashi M., Fujita T., Mimori T., Sakaguchi S. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med. 2010, 207:1135-1143.
25. Hawlisch H., Belkaid Y., Baelder R., Hildeman D., Gerard C., Köhl J. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 2005, 22:415-426.
26. Hawlisch H., Wills-Karp M., Karp C.L., Köhl J. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol. Immunol. 2004, 41:123-131.
27. Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., Lambris J.D., Warner R.L., Flierl M.A., Hoesel L.M., Gebhard F., Younger J.G., Drouin S.M., Wetsel R.A., Ward P.A. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 2006, 12:682-687.
28. Hugli T.E. Structure and function of the anaphylatoxins. Springer Semin. Immunopathol. 1984, 7:193-219.
29. Jagannath C., Hoffmann H., Sepulveda E., Actor J.K., Wetsel R.A., Hunter R.L. Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand. J. Immunol. 2000, 52:369-379.
30. Karp C.L., Grupe A., Schadt E., Ewart S.L., Keane-Moore M., Cuomo P.J., Köhl J., Wahl L., Kuperman D., Germer S., Aud D., Peltz G., Wills-Karp M. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 2000, 1:221-226.
31. Kawamoto S., Yalcindag A., Laouini D., Brodeur S., Bryce P., Lu B., Humbles A.A., Oettgen H., Gerard C., Geha R.S. The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. J. Clin. Invest. 2004, 114:399-407.
32. Kim A.H., Dimitriou I.D., Holland M.C., Mastellos D., Mueller Y.M., Altman J.D., Lambris J.D., Katsikis P.D. Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J. Immunol. 2004, 173:2524-2529.
33. Köhl J., Baelder R., Lewkowich I.P., Pandey M.K., Hawlisch H., Wang L., Best J., Herman N.S., Sproles A.A., Zwirner J., Whitsett J.A., Gerard C., Sfyroera G., Lambris J.D., Wills-Karp M. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J. Clin. Invest. 2006, 116:783-796.
34. Köhl J., Wills-Karp M. A dual role for complement in allergic asthma. Curr. Opin. Pharmacol. 2007, 7:283-289.
35. Köhl A., Tenner A.J., Johswich K.O., Ager R.R., Reis E.S., Köhl J. The role of the anaphylatoxins in health and disease. Mol. Immunol. 2009, 46:2753-2766.
36. Krug N., Tschernig T., Erpenbeck V.J., Hohlfeld J.M., Köhl J. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am. J. Respir. Crit. Care Med. 2001, 164:1841-1843.
37. Lajoie S., Lewkowich I.P., Suzuki Y., Clark J.R., Sproles A.A., Dienger K., Budelsky A.L., Wills-Karp M. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 2010, 11:928-935.
38. Lalli P.N., Strainic M.G., Lin F., Medof M.E., Heeger P.S. Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production. J. Immunol. 2007, 179:5793-5802.
39. Laufer J., Katz Y., Passwell J.H. Extrahepatic synthesis of complement proteins in inflammation. Mol. Immunol. 2001, 38:221-229.
40. Li K., Anderson K.J., Peng Q., Noble A., Lu B., Kelly A.P., Wang N., Sacks S.H., Zhou W. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 2008, 112:5084-5094.
41. Li K., Fazekasova H., Wang N., Sagoo P., Peng Q., Khamri W., Gomes C., Sacks S.H., Lombardi G., Zhou W. Expression of complement components, receptors and regulators by human dendritic cells. Mol. Immunol. 2011.
42. Li K., Sacks S.H., Zhou W. The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol. Immunol. 2007, 44:3866-3874.
43. Li Q., Peng Q., Xing G., Li K., Wang N., Farrar C.A., Meader L., Sacks S.H., Zhou W. Deficiency of C5aR prolongs renal allograft survival. J. Am. Soc. Nephrol. 2010, 21:1344-1353.
44. Liu J., Lin F., Strainic M.G., An F., Miller R.H., Altuntas C.Z., Heeger P.S., Tuohy V.K., Medof M.E. IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J. Immunol. 2008, 180:5882-5889.
45. Markiewski M.M., DeAngelis R.A., Benencia F., Ricklin-Lichtsteiner S.K., Koutoulaki A., Gerard C., Coukos G., Lambris J.D. Modulation of the antitumor immune response by complement. Nat. Immunol. 2008, 9:1225-1235.
46. Montz H., Koch K.C., Zierz R., Gotze O. The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology 1991, 74:373-379.
47. Morgan E.L. Modulation of the immune response by anaphylatoxins. Complement 1986, 3:128-136.
48. Morgan E.L., Thoman M.L., Hoeprich P.D., Hugli T.E. Bioactive complement fragments in immunoregulation. Immunol. Lett. 1985, 9:207-213.
49. Morgan E.L., Thoman M.L., Weigle W.O., Hugli T.E. Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J. Immunol. 1983, 130:1257-1261.
50. Morgan E.L., Weigle W.O., Hugli T.E. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses. J. Exp. Med. 1982, 155:1412-1426.
51. Moulton R.A., Mashruwala M.A., Smith A.K., Lindsey D.R., Wetsel R.A., Haviland D.L., Hunter R.L., Jagannath C. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice. J. Leukoc. Biol. 2007, 82:956-967.
52. Okinaga S., Slattery D., Humbles A., Zsengeller Z., Morteau O., Kinrade M.B., Brodbeck R.M., Krause J.E., Choe H.R., Gerard N.P., Gerard C. C5L2, a nonsignaling C5A binding protein. Biochemistry 2003, 42:9406-9415.
53. Peng Q., Li K., Anderson K., Farrar C.A., Lu B., Smith R.A., Sacks S.H., Zhou W. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 2008, 111:2452-2461.
54. Peng Q., Li K., Patel H., Sacks S.H., Zhou W. Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J. Immunol. 2006, 176:3330-3341.
55. Peng Q., Li K., Sacks S.H., Zhou W. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm. Allergy Drug Targets 2009, 8:236-246.
56. Peng Q., Li K., Wang N., Li Q., Asgari E., Lu B., Woodruff T.M., Sacks S.H., Zhou W. Dendritic cell function in allostimulation is modulated by C5aR signaling. J. Immunol. 2009, 183:6058-6068.
57. Pierce K.L., Premont R.T., Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 2002, 3:639-650.
58. Reis e Sousa Activation of dendritic cells: translating innate into adaptive immunity. Curr. Opin. Immunol. 2004, 16:21-25.
59. Snyderman R., Pike M.C. Chemoattractant receptors on phagocytic cells. Annu. Rev. Immunol. 1984, 2:257-281.
60. Sporri R., Reis e Sousa Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat. Immunol. 2005, 6:163-170.
61. Springall T., Sheerin N.S., Abe K., Holers V.M., Wan H., Sacks S.H. Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat. Med. 2001, 7:801-806.
62. Steinman R.M. Some interfaces of dendritic cell biology. APMIS 2003, 111:675-697.
63. Strainic M.G., Liu J., Huang D., An F., Lalli P.N., Muqim N., Shapiro V.S., Dubyak G.R., Heeger P.S., Medof M.E. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008, 28:425-435.
64. Takabayashi T., Shimizu S., Clark B.D., Beinborn M., Burke J.F., Gelfand J.A. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells. Surgery 2004, 135:544-554.
65. Tornetta M.A., Foley J.J., Sarau H.M., Ames R.S. The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression. J. Immunol. 1997, 158:5277-5282.
66. Ward P.A., Zvaifler N.J. Complement-derived leukotactic factors in inflammatory synovial fluids of humans. J. Clin. Invest. 1971, 50:606-616.
67. Weaver D.J., Reis E.S., Pandey M.K., Köhl G., Harris N., Gerard C., Köhl J. C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur. J. Immunol. 2010, 40:710-721.
68. Weigle W.O., Morgan E.L., Goodman M.G., Chenoweth D.E., Hugli T.E. Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells. Fed. Proc. 1982, 41:3099-3103.
69. Weinmann O., Gutzmer R., Zwirner J., Wittmann M., Langer K., Lisewski M., Mommert S., Kapp A., Werfel T. Up-regulation of C5a receptor expression and function on human monocyte derived dendritic cells by prostaglandin E2. Immunology 2003, 110:458-465.
70. Wills-Karp M. Complement activation pathways: a bridge between innate and adaptive immune responses in asthma. Proc. Am. Thorac. Soc. 2007, 4:247-251.
71. Xu R., Wang R., Han G., Wang J., Chen G., Wang L., Li X., Guo R., Shen B., Li Y. Complement C5a regulates IL-17 by affecting the crosstalk between DC and gammadelta T cells in CLP-induced sepsis. Eur. J. Immunol. 2010, 40:1079-1088.
72. Zhou J., Jang Y.P., Kim S.R., Sparrow J.R. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16182-16187.
73. Zhou W., Farrar C.A., Abe K., Pratt J.R., Marsh J.E., Wang Y., Stahl G.L., Sacks S.H. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J. Clin. Invest. 2000, 105:1363-1371.
74. Zhou W., Patel H., Li K., Peng Q., Villiers M.B., Sacks S.H. Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood 2006, 107:2461-2469.